Melexis stock: Degroof Petercam lifts rating for Melexis stock to Hold

Published on 10/21/2026 at 17:23 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Third-quarter results are due on October 28, 2026. Melexis stock costs EUR 58.03 on October 21, 2026, up 2.89 percent versus the Xetra close.

Rating and operating figures

Degroof Petercam moved Melexis from Reduce to Hold on October 16, 2026 and kept its EUR 56.00 target.
Second-quarter 2026 revenue reached EUR 217.10 million, up 2.60 percent from the prior-year quarter.
Melexis stock costs EUR 58.03 at Lang & Schwarz on October 21, 2026 at 5:11 p.m. CEST, 2.89 percent above the Xetra close of October 20, 2026.
Simply Wall St lists a price-to-earnings ratio of 22.4x and EUR 2.3 billion market capitalization as of October 20, 2026.

Bauhaus-Poster mit geometrischen Formen und Sektor-Schriftzug SENSOR — Bauhaus-Poster mit geometrischen Formen und Sektor-Text symbolisiert Melexis NV, ISIN BE0165385973, Halbleitersensoren fuer Automobilelektronik, Illustration mit AI erstellt.

Melexis (ISIN BE0165385973) received a rating upgrade from Reduce to Hold by Degroof Petercam on October 16, 2026, while the research firm kept its EUR 56.00 price target, according to Beursduivel. The current price is 3.63 percent above that target. At Lang & Schwarz, Melexis was trading at EUR 58.03 on October 21, 2026 at 5:11 p.m. CEST, up 2.89 percent versus the Xetra close.

October 28 results set the next test

Melexis is approaching its next scheduled reporting date with second-quarter 2026 figures as the latest operating reference. A September 5, 2026 results entry from Simply Wall St puts revenue at EUR 217.10 million, up 2.60 percent from the second quarter of 2025, while net income fell 19.00 percent to EUR 30.80 million. That combination makes revenue growth and profitability the key figures for the next update.

The share price sits above the target

Degroof Petercam's EUR 56.00 target is below the Lang & Schwarz price, but its rating change points to a less negative stance rather than a higher valuation threshold. The firm said the target was unchanged and removed Melexis from its short list, while noting that earnings expectations lacked a clear catalyst.

Valuation and reporting date

Simply Wall St lists Melexis at a 22.4x price-to-earnings ratio and a EUR 2.3 billion market capitalization as of October 20, 2026. The same analysis identifies October 28, 2026 for the third-quarter results, a date also cited by StoxEurope.

For investors, the figures create a clear checkpoint: the stock is above the latest analyst target, while the next report must show whether the second-quarter revenue improvement can be sustained without another margin setback.

Stock price and investor view

The Melexis price stood at EUR 58.03 at Lang & Schwarz on October 21, 2026 at 5:11 p.m. CEST, 2.89 percent above the Xetra close of October 20, 2026 at EUR 56.40. The next substantial company date is October 28, 2026, when third-quarter results are scheduled.

The further course of trading is shown by the continuously updated real-time quote of Melexis stock.